Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
DEA Cannabis Hearing Backfires as Opposition Witnesses Support Schedule III
Anti-reform witnesses at DEA's rescheduling hearing inadvertently strengthened the case for moving cannabis to Schedule III, undermining their own arguments.
DEA Cannabis Rescheduling Decision Timeline Extends Into 2026
Federal marijuana rescheduling hearings approach conclusion, but DEA action may not materialize until 2026, prolonging uncertainty for cannabis operators.
Cannabis Rescheduling Hearing Approaches Final Phase
Federal marijuana rescheduling proceedings near conclusion as DEA administrative process enters final stages, potentially reshaping industry landscape.
Aurora Cannabis Faces Fresh Scrutiny as Analysts Reassess Fundamentals
ACB stock draws renewed analyst attention amid shifting cannabis market dynamics and evolving investor expectations for profitability.
Bipartisan Cannabis Support Emerges as Political Lines Blur on Marijuana
New polling data shows marijuana support crossing traditional party lines, signaling potential regulatory shifts that could reshape the $30B+ cannabis market.
Cannabis Consumption Crosses Party Lines as Political Barriers Fade
New data reveals marijuana and alcohol use patterns show little partisan divide, signaling broader mainstream acceptance that could accelerate industry growth.
The Cannabist Company Volume Surges 330% Amid 4.29% Price Rally
CBSTF trading volume spiked to 5.4 million shares, more than triple its 30-day average, as the MSO gained 4.29% to $0.03 per share.
Green Thumb Industries Surges 7% on Strong Volume Amid MSO Rally
GTBIF jumped to $6.56 on elevated trading volume of 1.2M shares, signaling renewed investor interest in the multi-state operator.
Decibel Cannabis Surges 7.2% as Volume Spikes on OTC Markets
DBCCF climbed to $0.09 with elevated trading volume of 39,901 shares, approaching its 52-week high amid broader cannabis sector momentum.
Rapid-Onset Cannabis Products Gain Medical Market Traction
New fast-acting medical cannabis formulations target growing patient demand for precise dosing and immediate relief across therapeutic applications.
CRON Holds Ground Despite Cannabis Sector Volatility
Cronos Group maintains stable trading amid mixed cannabis earnings season, with strong balance sheet positioning company for strategic opportunities.
Cross-Border Cannabis M&A Faces Heightened Scrutiny Amid Market Volatility
International cannabis transactions demand deeper due diligence as regulatory complexity and market uncertainty amplify deal risks across jurisdictions.
Hydrofarm Holdings Plunges 6% as Cannabis Ancillary Faces Headwinds
HYFM dropped to $0.69 amid ongoing financial pressures, trading near 52-week lows with challenging debt-to-cash ratio.
Big Pharma, Drug Testing Firms Push Back on Cannabis Rescheduling
Pharmaceutical and drug testing companies warn Trump administration that moving cannabis to Schedule III will drive increased substance abuse nationwide.
Drug Testing, Pharma Industries Challenge Cannabis Rescheduling in Court
Industry groups file federal lawsuit seeking to halt cannabis rescheduling, claiming policy changes will increase abuse rates and harm public health.
Cannabis Rescheduling Hearing Concludes: What's Next for the Industry
Federal marijuana rescheduling hearing wraps up, leaving cannabis operators and investors waiting for regulatory clarity that could reshape tax burdens and market access.
Arkansas Medical Cannabis Market Stalls With $140M H1 Sales Drop
Arkansas medical cannabis sales fell 2.6% to $140.3M in first half of 2026, signaling market maturation challenges in established medical programs.
Cannabis Stocks Rally as Sector Outperforms Broader Markets
Select marijuana equities deliver strong returns amid renewed investor interest in the cannabis sector, signaling potential momentum shift.
San Francisco Legalizes Cannabis Cafés in Major Market Expansion Move
SF supervisors approve ordinance allowing cannabis cafés to serve food, drinks, and entertainment, creating new revenue streams for struggling dispensaries.
Cambria Cannabis ETF Sees 340% Volume Surge Amid Market Activity
TOKE experiences its highest trading volume in weeks as 54,299 shares change hands, more than triple the 30-day average of 16,164 shares.